HITNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31

Health In Tech, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.64−0.02 (-2.58%)

Close on Oct 19, 2026

Market cap: $39.90M
P/E (TTM): –
Dividend yield: –

Health In Tech, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash & Equivalents	7.67	7.85	2.42	1.49
Cash & Short-Term Investments	7.67	7.85	2.42	1.49
Receivables	0.76	1.65	2.24	–
Prepaid Expenses & Other	3.28	0.79	0.26	–
Total Current Assets	16	11	6.86	–
Operating Lease Right-of-Use Assets	0.14	0.21	0.27	–
Total Assets	23	16	12	–
Accounts Payable	4.19	1.86	2.62	–
Current Portion of Leases	0.08	0.07	0.06	–
Current Income Taxes Payable	–	0.21	0.45	–
Other Current Liabilities	0.89	–	–	–
Total Current Liabilities	5.16	2.13	4.78	–
Long-Term Leases	0.06	0.14	0.21	–
Operating Lease Liabilities	0.14	0.21	0.27	–
Deferred Tax Liabilities	0.76	0.33	0.42	–
Total Liabilities	5.98	2.60	5.41	–
Additional Paid-In Capital	12	9.17	2.77	–
Retained Earnings	5.22	3.94	3.27	–
Shareholders' Equity	17	13	6.09	–
Total Equity	17	13	6.09	1.42
Total Liabilities & Equity	23	16	12	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 53.9%
Operating margin: –
Net margin: -12.0%
Return on equity, FY2025: 8.4%

Financial strength

Current ratio: 2.18
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 65.2%

Valuation

P/E ratio: –
Price to sales: 1.22
Price to book: –
Dividend yield: –